ATAD1 and malaria: The results presented in this paper show no evidence of a difference in EBOV GP-specific binding antibody concentrations between categories of previous exposure to malaria infection based on antibody responses to six P. falciparum antigens indicative of long-term exposure (AMA-1, MSP-1.19 and GLURP.R2) and recent exposure, i.e., infection in the past ~9 months, (Rh2.2030, GEXP18 and Etramp5.Ag1) to malaria.